review · Cureus
Prostate cancer (PC) is considered the second most diagnosed cancer in men worldwide. It remains a leading cause of cancer-related death. Recently, many modalities have been discovered and used in the diagnosis and management of PC, with the incorporation of many treatment options such as hormonal therapy, chemotherapy, targeted therapies, immunotherapy, and precision medicine. Robotics and artificial intelligence (AI) have further modified the diagnosis and management of PCs, improving the diagnosis accuracy and disease progression. This comprehensive review offers an in-depth exploration of the historical modalities of treatments, an evaluation of current therapeutic techniques, a discussion of the use of robotic surgery and AI, and an examination of ongoing clinical trials and emerging procedures. Additionally, this review also covers the challenges. By inspecting these aspects, the review may provide valuable information regarding future research and clinical practice directions in PC treatment, contributing to a thorough understanding of the complex and emerging context of PC management.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.7759/cureus.73128
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.